Lack of Candida africana in Ugandan pregnant women: results from a pilot study using MALDI-ToF.
Humans
Female
Uganda
/ epidemiology
Pilot Projects
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
/ methods
Cross-Sectional Studies
Pregnancy
Candida
/ isolation & purification
Adult
Prevalence
Vagina
/ microbiology
Young Adult
Candida albicans
/ isolation & purification
Candida tropicalis
/ isolation & purification
Pichia
C. africana
C. albicans
C. glabrata
C. parapsilosis
C. tropicalis
Cyberlindnera jadinii
Pichia kudriavzevii
Uganda
Journal
BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768
Informations de publication
Date de publication:
24 Oct 2024
24 Oct 2024
Historique:
received:
25
06
2024
accepted:
14
10
2024
medline:
25
10
2024
pubmed:
25
10
2024
entrez:
25
10
2024
Statut:
epublish
Résumé
Candida africana is an emergent variant that has been listed as a new species or variety within the Candida albicans complex since 2001. It has a worldwide intra-albicans complex pooled prevalence of 1.67% and varies between 0 and 8% depending on geographical region. We present the results of a pilot study on its prevalence in Uganda. We conducted a cross-sectional study between March and June 2023. We recruited 4 pregnant women from Mulago Specialized Women and Neonatal Hospital, 102 from Kawempe National Referral Hospital, and 48 from Sebbi Hospital. Vaginal swabs were tested using microscopy, culture and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF). The prevalence of C. africana was zero. Out of the 103 isolates, the majority (81.553%) were identified as Candida albicans, followed by Nakeseomyces glabrata (13.592%) and Pichia kudriavzevii (1.942%). Cyberlindnera jadinii, Candida tropicalis, and Candida parapsilosis each accounted for 0.971% of the isolates. The prevalence of C. africana in Uganda is zero. However, large-scale cross-sectional studies, including studies involving the collection of vaginal samples from both urban and rural settings in Uganda and the use of both MALDI-TOF- and PCR-based laboratory methods, are needed to fully describe the public health burden of C. africana infections.
Sections du résumé
BACKGROUND
BACKGROUND
Candida africana is an emergent variant that has been listed as a new species or variety within the Candida albicans complex since 2001. It has a worldwide intra-albicans complex pooled prevalence of 1.67% and varies between 0 and 8% depending on geographical region. We present the results of a pilot study on its prevalence in Uganda.
METHODOLOGY
METHODS
We conducted a cross-sectional study between March and June 2023. We recruited 4 pregnant women from Mulago Specialized Women and Neonatal Hospital, 102 from Kawempe National Referral Hospital, and 48 from Sebbi Hospital. Vaginal swabs were tested using microscopy, culture and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF).
RESULTS
RESULTS
The prevalence of C. africana was zero. Out of the 103 isolates, the majority (81.553%) were identified as Candida albicans, followed by Nakeseomyces glabrata (13.592%) and Pichia kudriavzevii (1.942%). Cyberlindnera jadinii, Candida tropicalis, and Candida parapsilosis each accounted for 0.971% of the isolates.
CONCLUSION
CONCLUSIONS
The prevalence of C. africana in Uganda is zero. However, large-scale cross-sectional studies, including studies involving the collection of vaginal samples from both urban and rural settings in Uganda and the use of both MALDI-TOF- and PCR-based laboratory methods, are needed to fully describe the public health burden of C. africana infections.
Identifiants
pubmed: 39449135
doi: 10.1186/s13104-024-06973-8
pii: 10.1186/s13104-024-06973-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
321Informations de copyright
© 2024. The Author(s).
Références
Tietz HJ, Küssner A, Thanos M, De Andrade MP, Presber W, Schönian G. Phenotypic and genotypic characterization of unusual vaginal isolates of Candida albicans from Africa. J Clin Microbiol. 1995;33:2462–5.
doi: 10.1128/jcm.33.9.2462-2465.1995
pubmed: 7494047
Tietz HJ, Hopp M, Schmalreck A, Sterry W, Czaika V. Candida Africana sp. nov., a new human pathogen or a variant of. Candida albicans? Mycoses. 2001;44:437–45.
doi: 10.1046/j.1439-0507.2001.00707.x
pubmed: 11820255
Dieng Y, Sow D, Ndiaye M, et al. [Identification of three Candida Africana strains in Senegal]. J Mycol Medicale. 2012;22:335–40.
doi: 10.1016/j.mycmed.2012.07.052
Ngouana TK, Krasteva D, Drakulovski P, et al. Investigation of minor species Candida Africana, Candida stellatoidea and Candida Dubliniensis in the Candida albicans complex among Yaoundé (Cameroon) HIV-infected patients. Mycoses. 2015;58:33–9.
doi: 10.1111/myc.12266
pubmed: 25289589
Hana S, Latifa M, Camilia C, Boutheina J. Characterization of the ‘Candida albicans Complex’: first report of Candida Africana in Tunisia. J Med Microb Diagn. 2020;9:2.
Andeme S, Benmostef A, Chevalier A, Bouyou-Akotet M, Bailly E, Kombila M, Chandenier J, Hennequin C. Candida Africana: Un agent Fongique Commun Des Vaginites candidosiques à Libreville, Gabon. J Mycol Medicale. 2014;3:e120.
doi: 10.1016/j.mycmed.2014.06.026
Nnadi NE, Ayanbimpe GM, Scordino F, Okolo MO, Enweani IB, Criseo G, Romeo O. Isolation and molecular characterization of Candida Africana from Jos, Nigeria. Med Mycol. 2012;50:765–7.
doi: 10.3109/13693786.2012.662598
pubmed: 22380533
Racha B, Khaled A, Haïet A-H, Yasmine B, Lamine L, Djazia D, Linda B, Lyes C, Mohsen S, Fatma B. Première caractérisation moléculaire de Candida africana en Algérie. J Mycol Médicale. 2016;26:68–9.
doi: 10.1016/j.mycmed.2016.02.007
Gharehbolagh SA, Fallah B, Izadi A, Ardestani ZS, Malekifar P, Borman M, Mahmoudi A S. Distribution, antifungal susceptibility pattern and intra-candida albicans species complex prevalence of Candida Africana: a systematic review and meta-analysis. PLoS ONE. 2020;15:e0237046.
doi: 10.1371/journal.pone.0237046
pubmed: 32817677
Bongomin F, Kwizera R, Namusobya M, van Rhijn N, Andia-Biraro I, Kirenga BJ, Meya DB, Denning DW. Re-estimation of the burden of serious fungal diseases in Uganda. Ther Adv Infect Dis. 2024;11:20499361241228345.
pubmed: 38328511
Mushi MF, Olum R, Bongomin F. Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub-saharan Africa: a systematic review with meta-analysis and meta-regression. Med Mycol. 2022;60:myac037.
doi: 10.1093/mmy/myac037
pubmed: 35781514
Osman Mohamed A, Suliman Mohamed M, Hussain Mallhi T, Abdelrahman Hussain M, Ali Jalloh M, Ali Omar K, Omar Alhaj M, Makki Mohamed Ali AA. Prevalence of vulvovaginal candidiasis among pregnant women in Africa: a systematic review and meta-analysis. J Infect Dev Ctries. 2022;16:1243–51.
doi: 10.3855/jidc.15536
pubmed: 36099366
Naing L, Nordin RB, Abdul Rahman H, Naing YT. Sample size calculation for prevalence studies using scalex and ScalaR calculators. BMC Med Res Methodol. 2022;22:209.
doi: 10.1186/s12874-022-01694-7
pubmed: 35907796
Mucci MJ, Cuestas ML, Landanburu MF, Mujica MT. Prevalence of Candida albicans, Candida Dubliniensis and Candida Africana in pregnant women suffering from vulvovaginal candidiasis in Argentina. Rev Iberoam Micol. 2017;34:72–6.
doi: 10.1016/j.riam.2016.09.001
pubmed: 28385421
Yazdanpanah A, Khaithir TMN. Issues in identifying germ tube positive yeasts by conventional methods. J Clin Lab Anal. 2014;28:1–9.
doi: 10.1002/jcla.21635
pubmed: 24375729
Gumral R, Sancak B, Guzel AB, Saraçlı MA, Ilkit M. Lack of Candida Africana and Candida Dubliniensis in vaginal Candida albicans isolates in Turkey using HWP1 gene polymorphisms. Mycopathologia. 2011;172:73–6.
doi: 10.1007/s11046-011-9401-2
pubmed: 21380767
Romeo O, Criseo G. First molecular method for discriminating between Candida Africana, Candida albicans, and Candida Dubliniensis by using hwp1 gene. Diagn Microbiol Infect Dis. 2008;62:230–3.
doi: 10.1016/j.diagmicrobio.2008.05.014
pubmed: 18640803
Nikmanesh B, Ahmadikia K, Getso MI, Gharehbolagh SA, Aboutalebian S, Mirhendi H, Mahmoudi S. Candida Africana and Candida Dubliniensis as causes of pediatric candiduria: a study using HWP1 gene size polymorphism. AIMS Microbiol. 2020;6:272–9.
doi: 10.3934/microbiol.2020017
pubmed: 33134744
Theill L, Dudiuk C, Morano S, Gamarra S, Nardin ME, Méndez E, Garcia-Effron G. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida Dubliniensis and Candida Africana isolated from vulvovaginal samples in a hospital of Argentina. Rev Argent Microbiol. 2016;48:43–9.
pubmed: 26922471
Criseo G, Scordino F, Romeo O. Current methods for identifying clinically important cryptic Candida species. J Microbiol Methods. 2015;111:50–6.
doi: 10.1016/j.mimet.2015.02.004
pubmed: 25659326
Romeo O, Criseo G. Molecular epidemiology of Candida albicans and its closely related yeasts Candida Dubliniensis and Candida Africana. J Clin Microbiol. 2009;47:212–4.
doi: 10.1128/JCM.01540-08
pubmed: 18987171
Rodríguez-Leguizamón G, Fiori A, López LF, Gómez BL, Parra-Giraldo CM, Gómez-López A, Suárez CF, Ceballos A, Van Dijck P, Patarroyo MA. Characterising atypical Candida albicans clinical isolates from six third-level hospitals in Bogotá, Colombia. BMC Microbiol. 2015;15:199.
doi: 10.1186/s12866-015-0535-0
pubmed: 26438104
Ingle S, Kodgire S, Shiradhone A, Patil R, Zore G. Chlamydospore Specific Proteins of Candida albicans. Data. 2017;2:26.
doi: 10.3390/data2030026
Duggan S, Usher J. Candida Glabrata: a powerhouse of resistance. PLOS Pathog. 2023;19:e1011651.
doi: 10.1371/journal.ppat.1011651
pubmed: 37796755
Fallahi S, Babaei M, Rostami A, Mirahmadi H, Arab-Mazar Z, Sepahvand A. Diagnosis of Candida albicans: conventional diagnostic methods compared to the loop-mediated isothermal amplification (LAMP) assay. Arch Microbiol. 2020;202:275–82.
doi: 10.1007/s00203-019-01736-7
pubmed: 31641798
Westblade LF, Jennemann R, Branda JA, et al. Multicenter Study evaluating the Vitek MS System for Identification of medically important yeasts. J Clin Microbiol. 2013;51:2267–72.
doi: 10.1128/JCM.00680-13
pubmed: 23658267